A record for the reading desk
Semaglutide
Aliases: Wegovy
The recorded fields, their references, and a question worth keeping.
- Status
- Approved product
- Evidence label
- Randomized evidence
- Index topics
- Metabolism
- Status as of
Record / 01
Recorded fields
- Mechanism
- Activates the GLP-1 receptor.
- Evidence
- Randomized trials.
- Limitations
- Check other products separately.
- Safety
- Severe or persistent gastrointestinal symptoms: contact a clinician.
- Route context
- This entry covers subcutaneous Wegovy injection.
- Approval scope
- Wegovy injection: weight management in eligible adults.
Reasoning / 02
A note for your reading
An overall ranking can depend on how its ingredients are weighted. Imagine a comparison that combines clarity, completeness, and convenience into a single score. Giving clarity more influence could change the order even if every underlying assessment stayed the same. To understand the ranking, uncover that combining rule before debating the winner. Then consider another reasonable set of weights. If the order changes, the useful conclusion includes the preference that produced it. Keeping the ingredients visible lets a reader distinguish disagreement about the assessments from disagreement about what deserves the most emphasis.
Keep asking / 03
Three questions to carry forward
- How much influence does each ingredient have on the combined score?
- Would another reasonable weighting change the order without changing the underlying assessments?
- Does the disagreement concern the assessments themselves or the emphasis given to each?
Trace the record / 04
References
- WEGOVY
NLM · Checked
- Wegovy approval
FDA · Checked